The broad long-term objectives of this proposal are to understand the mechanisms involved in signaling through the cyclic GMP pathway, the normal biological role of PP5, a protein-serine phosphatase that is phosphorylated and activated by cyclic GMP-dependent protein kinase (PKG), and the role of tetratricopeptide repeat (TPR) domains in subcellular targeting.
The specific aims are to: i) identify the mechanisms regulating the binding of PP5 to the atrial natriuretic peptide (ANP) receptor/guanylyl cyclase (GC-A); PP5 is targeted to GC-A and appears to mediate GC-A dephosphorylation and desensitization; ii) identify the residues in PP5 that are phosphorylated by PKG and test whether the amino-terminal regulatory domain of PP5 is autoinhibitory; test whether PKG activates PP5 by relieving autoinhibition; iii) determine the structural requirements for PP5 targeting to GC-A. The health relatedness of the project lies in gaining a better understanding of (1) the mechanisms of action of natriuretic peptides that are potential therapeutic agents, and the mechanisms by which responsiveness to these peptides is lost in cardiovascular disease states; (2) of the PKG signaling pathway, which mediates diverse hormonal responses. The experimental plan is: i) to use metabolic labeling and immunoprecipitation to test whether PP5 is phosphorylated by PKG and PKC in intact cells. To perform co-immunoprecipitation experiments to test whether treatments with ANP, TPA, or 8-bromo cyclic GMP increase association of PP5 with GC-A. To use in vitro membrane-binding assays and surface plasmon resonance assays to test effects of PP5 phosphorylation on its binding to the kinase-domain of GC-A; ii) to use phosphoamino acid analysis, phosphopeptide mapping, and peptide sequencing to identify sites on PP5 phosphorylated by PKG. To use deletion mutagenesis and phosphatase assays to test whether the amino terminal regulatory domain of PP5 contains autoinhibitory sequences; iii) to use deletion mutagenesis and in vitro binding assays to identify the minimal structural requirements for binding of the PP5 TPR domain to the GC-A kinase-like domain, to use site directed mutagenesis of full-length PP5 and GC-A, in conjunction with co-immunoprecipitation and desensitization assays, to test the in vivo importance of residues identified as important for binding in vitro.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL047063-07
Application #
6030628
Study Section
Biochemistry Study Section (BIO)
Project Start
1991-08-01
Project End
2001-06-30
Budget Start
1999-07-01
Budget End
2000-06-30
Support Year
7
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of South Alabama
Department
Pharmacology
Type
Schools of Medicine
DUNS #
City
Mobile
State
AL
Country
United States
Zip Code
36688
Chinkers, M (2001) Protein phosphatase 5 in signal transduction. Trends Endocrinol Metab 12:28-32
Kang, H; Sayner, S L; Gross, K L et al. (2001) Identification of amino acids in the tetratricopeptide repeat and C-terminal domains of protein phosphatase 5 involved in autoinhibition and lipid activation. Biochemistry 40:10485-90
Kumar, R; Grammatikakis, N; Chinkers, M (2001) Regulation of the atrial natriuretic peptide receptor by heat shock protein 90 complexes. J Biol Chem 276:11371-5
Ramsey, A J; Russell, L C; Whitt, S R et al. (2000) Overlapping sites of tetratricopeptide repeat protein binding and chaperone activity in heat shock protein 90. J Biol Chem 275:17857-62
Wu, S; Moore, T M; Brough, G H et al. (2000) Cyclic nucleotide-gated channels mediate membrane depolarization following activation of store-operated calcium entry in endothelial cells. J Biol Chem 275:18887-96
Russell, L C; Whitt, S R; Chen, M S et al. (1999) Identification of conserved residues required for the binding of a tetratricopeptide repeat domain to heat shock protein 90. J Biol Chem 274:20060-3
Reddy, R K; Kurek, I; Silverstein, A M et al. (1998) High-molecular-weight FK506-binding proteins are components of heat-shock protein 90 heterocomplexes in wheat germ lysate. Plant Physiol 118:1395-401
Silverstein, A M; Grammatikakis, N; Cochran, B H et al. (1998) p50(cdc37) binds directly to the catalytic domain of Raf as well as to a site on hsp90 that is topologically adjacent to the tetratricopeptide repeat binding site. J Biol Chem 273:20090-5
Chinkers, M (1997) Mapping of Ppp5c, the gene encoding protein phosphatase 5, to mouse chromosome 7. Mamm Genome 8:538-9
Silverstein, A M; Galigniana, M D; Chen, M S et al. (1997) Protein phosphatase 5 is a major component of glucocorticoid receptor.hsp90 complexes with properties of an FK506-binding immunophilin. J Biol Chem 272:16224-30

Showing the most recent 10 out of 14 publications